Siemens Healthineers at RSNA 2018

We enable you to deliver high-value care

Siemens Healthineers at RSNA 2018
 
Follow Us On Social Media

RSNA 2018 - Radiological Society of North America

Thank you for visiting us at RSNA 2018. We hope you enjoyed it as much as we did!

Hopefully, you had a chance to meet our experts in person and explore how you can increase value by expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare.
If you weren’t there in person or couldn’t see everything you had planned, you can watch video highlights from our booth below or you can visit our Press Room for all the RSNA press releases and comprehensive background information.

Looking forward to meet you next year at RSNA 2019, 1 Dec 2019 - 6 Dec 2019

RSNA Videos

RSNA 2018: Digital Twin - a customized computational model of the patient

Artificial intelligence (AI) is transforming care delivery and expanding precision medicine. Siemens Healthineers has served as a pioneer in AI development for more than 20 years, and new deep learning technology now enables us to automate complex diagnostics and support optimal treatment.

2018 RSNA: Leverage AI for Clinical Routine

AI-powered tools are transforming care delivery. At RSNA18, we highlighted our full suite of digital offerings including the new AI Companion platform, which includes AI-Rad Companion4 for Radiology and AI-Pathway Companion5 for support along clinical pathways. Colleagues Jörg Aumüller and Razvan Lonasec give the details from the RSNA show floor.

RSNA 2018: Interventional Radiology – Prostate Artery Embolization (PAE)

Dr. Ricardo Garcia-Monaco, Chief of Diagnostics and Interventional Radiology at Hospital Italiano de Buenes Aires, Argentina, explains the principles of PAE and how it’s transforming care for men suffering from enlarged prostate.

RSNA 2018: Movember, Men’s Health, and AI-Pathway Companion

At RSNA 2018, colleagues Tina Manoharan and Mario Zeiss discuss how our technologies are helping healthcare professionals make more precise decisions along the prostate cancer clinical pathway.

RSNA 2018: Expanding Access – Syngo Virtual Cockpit + Biomatrix

We are expanding boundaries with our imaging technology, and we are also focusing on expanding access to care. At RSNA 2018, we introduced the Syngo Virtual Cockpit which gives virtual access to an expert technologist at up to 3 locations. Plus, we expanded our MRI systems featuring BioMatrix technology.

RSNA 2018: Improving patient experience and deliver outcome that matters

At RSNA 2018, we showcased how we are dedicated to helping practitioners improve patient experience. Colleague Felix Müller-Witt explains how we are improving the diagnostic experience and Philip Stenner details how advancement in stroke treatments can determine better outcomes for the patients.3

RSNA 2018: Optimize clinical operations

Part of transforming care delivery is to optimize clinical operations. Colleagues Robert Lapp and Gregor Thoermer shares with us how we can improve operational performance by standardize imaging protocols and shorten image acquisition time for certain scans.

RSNA 2018: Artificial Intelligence and Women's Health

As in other modalities, the case load for the radiologists focused on women’s health is increasing. Colleague Abigail Weldon details how solutions powered by artificial intelligence may be able to help.

RSNA 2018: Wide-angle 50-degree Tomosynthesis with Dr. Brandie Fagin

Using a wide-angle 50-degree Tomosynthesis collection allows Dr. Brandie Fagin of Rush Oak Park Hospital to more easily visualize the more abnormal lesions and reduce the number of screening procedures necessary to diagnose. Hear more about Dr. Fagin’s success.

RSNA 2018: The future of interventional radiology

Dr. Christian Loewe from Vienna General Hospital in Austria joins us at the 2018 RSNA to discuss the future of interventional radiology and how new technology such as multimodality imaging therapy suites like the Nexaris has the potential to open doors to new kinds of treatments.

Product Highlights

Follow Us on Social Media

Get the latest news and updates before, during and after RSNA 2018

1510(k) pending. It is not commercially available in all countries. Due to regulatory reasons the future availability cannot be guaranteed.

2510(k) pending. It is not commercially available in all countries. Due to regulatory reasons the future availability cannot be guaranteed.

3This product is under development and not commercially available. Its future availability cannot be ensured.

4AI-Rad Companion is pending 510(k) clearance, and not yet commercially available in the United States and other countries.

5AI-Pathway Companion is currently under development. It is not for sale in the U.S. Its future availability cannot be guaranteed.